Rapid Micro Biosystems, Inc. (RPID) financial statements and ratios from SEC XBRL: revenue $33.59M (TTM), net margin -140.3%, revenue growth 19.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $33.59M |
| Net Margin | -140.3% |
| Revenue Growth (YoY) | 19.7% |
| EPS Growth (YoY) | -2.8% |
| FCF Growth (YoY) | -29.9% |
| Price / Book | 4.55 |
| Price / Sales | 2.53 |
| FCF Yield | -108.3% |
| Altman Z-Score | -9.65 (distress) |
| Sector P/E (Technology) | 33.9 |
RPID overview · RPID earnings · RPID KPIs · RPID investor relations · RPID ownership · RPID peers · RPID filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.